Ethanolic Extract of Hedyotis corymbosa and Its Combination with 5-FU Inhibit Cyclin D Expression on WiDr Colorectal Cancer Cell

Argandita Meiftasari, Januar Caesar W.P., Annisa Novarina, Julika Yovi W., Riris Istighfari Jenie

Abstract


Hedyotis corymbosa has been used for long time as an important component in several folklore medicine formula to clinically treat various types of cancer, including colorectal cancer (CRC). Previously, Hedyotis corymbosa ethanolic extract (HEE) which contain ursolic acid reported to inhibit CRC growth via induction of cancer cell apop­tosis and blocked the cell cycle, preventing G1 to S progression where cyclin D highly espressed in this phase. 5-fluorouracil (5FU), the first line chemotherapy of colorectal cancer have had resistence and possessed several side effects such as neutropenia, immunosuppression, diarrhea, and also constipation. Therefore, the aim of this research is to conduct the antiproliferative effect and molecular analysis of HEE and its combination with 5FU. Molecular docking study was also done to approach the specific protein target of the compound. Antiproliferative effect was conducted by MTT assay, while cyclin D expression  was examined by immunofluorescence. The proliferative effect showed that both HEE and 5-FU had cytotoxic effect with IC50 value of 65 µg/mL and 90 µM respectively, meanwhile the combination of HEE and 5FU have synergism effect with CI = 0.48 on dose HEE = 22 µg/mL and 5FU= 6.25 µM. Immunofluorescence assay showed HEE and its combination with 5FU suppressed the expression of cyclin D. From molecular docking simulation, ursolic acid performed stable interaction with cyclin D. Our findings suggest that HEE may be an effective treat­ment for co-chemotherapic for 5-FU through inhibition of cyclin D expression.

Keywords : Hedyotis corymbosa, 5-fluorouracil, colorectal cancer,  WiDr, cyclin D 


Full Text:

PDF

References


American Cancer Society. Colorectal Cancer Facts & Figures 2014-2016. Atlanta: American Cancer Society, 2014.

Bertoli, C., Skotheim, J. M. and de Bruin, R. A. M., 2013, Control of Cell Cycle Transcription During G1 and S Phases, Nat. Rev. Mol. Cell Biol., 14(8),518 – 528. CrossRef

Nurse, P., 1994, Ordering S Phase and M Phase in the Cell Cycle, Cell, 79(4),547-550. Link

Chen, Y., Robles, A.I., Martinez, L.A., Liu, F., Gimenez-Conti, I.B. and Conti, C.J., 1996. Expression of G1 Cyclins, Cyclin-dependent Kinases, and Cyclin-Dependent Kinase Inhibitors in Androgen-induced Prostate Proliferation in Castrated Rats, Cell Growth Differ., 7(11), 1571-1578. Link

Denise, C., Paoli, P., Calvani, M., Taddei, M. L., Giannoni, E., Kopetz, S., et al., 2015, 5-Fluorouracil Resistant Colon Cancer Cells are Addicted to OXPHOS to Survive and Enhance Stem-likeTraits, Oncotarget,6(39), 41706–41721. Link

Giovannetti, E., Backus, H.H.J., Wouters, D., Ferreira,C.G., van Houten, V.M.M., Brakenhoff, R.H., et al., 2007, Changes in the Status of p53 Affect Drug Sensitivity to Thymidylate Synthase (TS) Inhibitors by Altering TS Levels, Br. J. Cancer, 96(5),769-775. CrossRef

Graña, X. and Reddy, E,P., 1995, Cell Cycle Control in Mammalian Cells: Role of Cyclins, Cyclin Dependent Kinases (CDKs), Growth Suppressor Genes and Cyclin-dependent Kinase Inhibitors (CKIs), Oncogene, 11(2), 211-219. Link

Gressett, S.M., Stanford, B.L. and Hardwicke, F., 2006, Management of Hand-Foot Syndrome Induced by Capecitabine, J. Oncol. Pharm. Pract., 12,131–141. CrossRef

Kelloff, G.J.,2000, Perspectives on Cancer Chemoprevention Research and Drug Development, Adv. Cancer Res., 78, 199-334. Link

Jeune, M.A., Kumi-Diaka, J. and Brown, J.,2005, Anticancer Activities of Pomegranate Extracts and Genistein in Human Breast Cancer Cells, J. Med. Food, 8(4), 469-475. CrossRef

Meyerhardt, J.A. and Mayer, R.J., 2005, Systemic Therapy for Colorectal Cancer, N. Engl. J. Med., 352(5),476-484. CrossRef

Mosmann, T., 1983, Rapid Colorimetric Assay for Cellular Growth and Survival : Application to Proliferation and Cytotoxicity Assay, J. Immunol. Methods, 65(1-2),55-63. Link

Peters, G.J., Backus, H.H.J., Freemantle, S., van Triest, B., Pisanelli, G.C., van der Wilt, C.L., et al., 2002, Induction of Thymidylate Synthase as a 5-fluorouracil Resistannce Mechanism, Biochim. Biophys. Acta, 1587(2-3),194-205. Link

Won HJ, Han CH, Kim YH, Kwon HJ, Kim BW, Choi JS., et al., 2006, Induction of Apoptosis in Human Acute Leukemia Jurkat T Cells by Albizzia julibrissin Extract is Mediated via Mitochondria-dependent Caspase-3 Activation, J. Ethnopharmacol., 106(3),383-389. CrossRef




DOI: http://dx.doi.org/10.14499/indonesianjcanchemoprev7iss1pp25-30

Copyright (c) 2017 Indonesian Journal of Cancer Chemoprevention

Indexed by:

               

               

      

 

Indonesian Society for Cancer Chemoprevention